Savant Capital, LLC Novartis Ag Transaction History

Savant Capital, LLC

  • $11.7 Billion
  • Q3 2024

A detailed history of Savant Capital, LLC transactions in Novartis Ag stock. As of the latest transaction made, Savant Capital, LLC holds 11,371 shares of NVS stock, worth $1.12 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
11,371
Previous 5,463 108.15%
Holding current value
$1.12 Million
Previous $581,000 124.96%
% of portfolio
0.01%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024
BUY
$106.13 - $120.89 $627,016 - $714,218
5,908 Added 108.15%
11,371 $1.31 Million
Q2 2024

Aug 05, 2024
BUY
$92.57 - $107.37 $5,183 - $6,012
56 Added 1.04%
5,463 $581,000
Q1 2024

May 03, 2024
SELL
$95.27 - $108.47 $199,685 - $227,353
-2,096 Reduced 27.94%
5,407 $523,000
Q4 2023

Feb 05, 2024
BUY
$92.27 - $101.54 $344,905 - $379,556
3,738 Added 99.28%
7,503 $757,000
Q3 2023

Nov 06, 2023
SELL
$94.73 - $105.13 $31,450 - $34,903
-332 Reduced 8.1%
3,765 $383,000
Q2 2023

Aug 04, 2023
BUY
$92.52 - $104.91 $51,718 - $58,644
559 Added 15.8%
4,097 $413,000
Q1 2023

May 02, 2023
SELL
$80.03 - $92.81 $1,680 - $1,949
-21 Reduced 0.59%
3,538 $325,000
Q4 2022

Feb 06, 2023
BUY
$75.55 - $92.52 $268,882 - $329,278
3,559 New
3,559 $322,000
Q2 2022

Jul 22, 2022
BUY
$80.52 - $93.75 $15,781 - $18,375
196 Added 6.91%
3,034 $256,000
Q1 2022

May 05, 2022
SELL
$80.11 - $90.62 $1,922 - $2,174
-24 Reduced 0.84%
2,838 $249,000
Q4 2021

Feb 08, 2022
BUY
$79.7 - $88.13 $25,982 - $28,730
326 Added 12.85%
2,862 $250,000
Q3 2021

Nov 12, 2021
SELL
$81.78 - $95.14 $17,746 - $20,645
-217 Reduced 7.88%
2,536 $207,000
Q2 2021

Aug 04, 2021
SELL
$85.24 - $94.15 $18,497 - $20,430
-217 Reduced 7.31%
2,753 $251,000
Q1 2021

May 04, 2021
SELL
$83.5 - $98.47 $2,505 - $2,954
-30 Reduced 1.0%
2,970 $254,000
Q4 2020

Feb 03, 2021
BUY
$78.07 - $94.43 $546 - $661
7 Added 0.23%
3,000 $283,000
Q3 2020

Nov 04, 2020
SELL
$82.14 - $91.0 $14,703 - $16,289
-179 Reduced 5.64%
2,993 $260,000
Q2 2020

Aug 11, 2020
BUY
$80.93 - $91.1 $32,695 - $36,804
404 Added 14.6%
3,172 $277,000
Q1 2020

Apr 30, 2020
BUY
$70.67 - $99.01 $195,614 - $274,059
2,768 New
2,768 $228,000

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Savant Capital, LLC Portfolio

Follow Savant Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Savant Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Savant Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email